Teva Pharmaceutical Industries (TEVA) Amortization - Intangibles: 2015-2017
Historic Amortization - Intangibles for Teva Pharmaceutical Industries (TEVA) over the last 1 years, with Sep 2017 value amounting to $7.5 billion.
- Teva Pharmaceutical Industries' Amortization - Intangibles rose 16.20% to $7.5 billion in Q3 2017 from the same period last year, while for Sep 2017 it was $21.3 billion, marking a year-over-year change of. This contributed to the annual value of $6.5 billion for FY2016, which is 9.89% up from last year.
- Per Teva Pharmaceutical Industries' latest filing, its Amortization - Intangibles stood at $7.5 billion for Q3 2017, which was up 1,361.28% from $514.0 million recorded in Q2 2017.
- Over the past 5 years, Teva Pharmaceutical Industries' Amortization - Intangibles peaked at $7.5 billion during Q3 2017, and registered a low of $514.0 million during Q2 2017.
- In the last 3 years, Teva Pharmaceutical Industries' Amortization - Intangibles had a median value of $6.5 billion in 2016 and averaged $5.6 billion.
- Data for Teva Pharmaceutical Industries' Amortization - Intangibles shows a peak YoY rose of 16.20% (in 2017) over the last 5 years.
- Over the past 3 years, Teva Pharmaceutical Industries' Amortization - Intangibles (Quarterly) stood at $5.9 billion in 2015, then increased by 9.89% to $6.5 billion in 2016, then grew by 16.20% to $7.5 billion in 2017.
- Its Amortization - Intangibles was $7.5 billion in Q3 2017, compared to $514.0 million in Q2 2017 and $6.8 billion in Q1 2017.